v3.25.4
EARNINGS PER SHARE (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Numerator:      
Net income from continuing operations $ 2,154 $ 2,050 $ 1,618
Net (income) loss attributable to noncontrolling interests (70) (57) (46)
Net income from continuing operations attributable to GE HealthCare 2,084 1,993 1,572
Deemed preferred stock dividend of redeemable noncontrolling interest 0 0 (183)
Net income from continuing operations attributable to GE HealthCare common stockholders 2,084 1,993 1,389
Income (loss) from discontinued operations, net of taxes 0 0 (4)
Net income attributable to GE HealthCare common stockholders $ 2,084 $ 1,993 $ 1,385
Denominator:      
Basic weighted-average shares outstanding 456 456 455
Dilutive effect of common stock equivalents (in shares) 1 2 3
Diluted weighted-average shares outstanding 458 459 458
Basic Earnings Per Share:      
Continuing operations (in dollars per share) $ 4.56 $ 4.37 $ 3.06
Discontinued operations (in dollars per share) 0 0 (0.01)
Basic earnings per share (in dollars per share) 4.56 4.37 3.05
Diluted Earnings Per Share:      
Continuing operations (in dollars per share) 4.55 4.34 3.04
Discontinued operations (in dollars per share) 0 0 (0.01)
Diluted earnings per share (in dollars per share) $ 4.55 $ 4.34 $ 3.03
Antidilutive securities (in shares) 3 3 4